QIAGEN powered by

Live Expert Panel: Clinical and Economic Value of NGS Testing

Date: 2020/10/22 Duration: 01:00:00 Presented by: Expert Panel

On Thursday, October 22, a live expert panel will discuss the clinical and economic value of NGS testing in oncology. The experts will analyze two recent studies that compare the clinical utility and cost-effectiveness of multi-gene NGS testing vs. single gene testing for non-small-cell lung cancer. Although NGS testing is becoming a routine part of clinical cancer care, the studies found that NGS testing currently offers statistically insignificant improvements in population-level overall survival and cost-effectiveness.

Hear from the experts as they explore the causes of this practice gap and offer strategies for improving the end-benefit of NGS testing.

Learning objectives:

  • Gain an understanding of the data, methodologies, and limitations of these two studies
  • Examine the gaps in clinical practice that were revealed, including availability and interpretation of NGS tests, access to and reimbursement for targeted therapies, and awareness of the rapidly evolving knowledge in the field of precision medicine
  • Assess the value of NGS testing in light of the data presented and advances in the field since the data was collected and analyzed